The Fungal Srebp Pathway As a Target for Anti-fungal Agents
Inhibition of Srel activity and/or expression has great potential for antifungal therapeutics. Disclosed herein are novel methods and compositions useful for the identification of novel inhibitors of Srel activity and/or function and the treatment of fungal infections.
Patents:WO 2,011,031,471
Inventor(s):
ESPENSHADE PETER J [US]; BIEN CLARA M [US]
Type of Offer:
Licensing
« More Medical Patents